- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05699642
Online Tai Chi Plus Fitbit After ACS (Mind2Move)
February 2, 2026 updated by: Gloria Y. Yeh, Beth Israel Deaconess Medical Center
Tai Chi Exercise and Wearable Feedback Technology to Promote Physical Activity in Acute Coronary Syndrome Survivors
This projects studies the role of tai chi exercise and wearable fitness trackers to promote physical activity in acute coronary syndrome (ACS) survivors.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
This is a two-site randomized controlled trial taking place at Beth Israel Deaconess Medical Center in Boston, MA and The Miriam Hospital in Providence, RI.
Seventy (n=70) physically inactive ACS survivors will be randomized to either a 6-month group tai chi program (remotely-delivered classes on Zoom) integrated with a wearable self-monitoring/feedback device plus enhanced usual care (EUC), or to EUC alone.
EUC will include usual care provided by participants' providers integrated with printed CHD risk factor education materials.
Assessments will be conducted in-person at baseline, 6 months (end of treatment), and 9 months.
Our primary outcomes will be focused on study feasibility and acceptability.
Secondary outcomes include the following patient-centered outcomes: objectively measured (via accelerometry) moderate-vigorous physical activity, light physical activity, sedentary time, cognitive-behavioral constructs (exercise self-efficacy, intrinsic motivation, depression, stress, HRQL), and cardiometabolic measures (exercise capacity, body weight, lipid profile, blood pressure, fasting plasma glucose).
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- History of ACS (unstable angina, NSTEMI, and STEMI, defined per current AHA/ACC criteria);
- Age ≥ 18;
- Being physically inactive (i.e., < 150 min/week of moderate-intensity aerobic PA);
- Absence of contraindications to physical exercise per the participant's provider evaluation;
- Access to a digital device with internet connection;
- Having an active email account and ability to check email at least weekly;
- Physician clearance to participate in low-moderate intensity exercise (tai chi), including a statement that there is no contraindication to exercise based on post-ACS stress test and other factors, as appropriate;
- English speaking
Exclusion Criteria:
- Inability or unwillingness to give informed consent;
- Blood pressure >200/110 or orthostatic systolic blood pressure decrease >20 mmHg at the baseline visit;
- Uncontrolled/untreated atrial or ventricular arrhythmias or 3rd degree AV block;
- Within 3 months of a diagnosis of pericarditis or myocarditis;
- Medical conditions likely to limit lifespan to less than one year;
- New York Heart Association (NYHA) functional class IV;
- Severe cognitive impairment (BOMC >10);139
- Orthopedic problems prohibiting TC practice;
- Ongoing TC or other mind-body training (i.e., meditation, TC, or yoga) at least weekly;
- Current enrollment in cardiac rehabilitation;
- Untreated severe depression (PHQ>=20);
- Conditions likely to affect study compliance (i.e., moving out of study area, substance use, ongoing untreated psychosis);
- Symptoms of unstable cardiovascular disease (e.g., shortness of breath or chest pain at rest and/or Canadian Cardiovascular Society Angina Class III-IV)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tai chi + wearable
48 virtual tai chi classes on Zoom over 6 months plus assigned home practice of tai chi 3x a week plus daily use of a Fitbit fitness tracker will be required for this group.
|
The tai chi intervention will be delivered remotely via Zoom Enterprise.
Participants will access classes on a phone, tablet, laptop, or desktop computer.
Participants will attend 3 classes/week (each lasting 60 min) during weeks 1-12, 2 classes/week during weeks 13-16, and then 1 class every other week during weeks 17-24.
Classes include tai chi warm-up exercises, breathing exercises, review and practice of tai chi forms, and cool-down exercises.
Participants will be asked to practice tai chi at home 3x per week during the 6 month intervention period using an instructional video provided to them.
The Fitbit fitness tracker will be given to each participant along with instructions on how to use the tracker and the Fitbit app on their personal device.
|
|
No Intervention: Enhanced usual care
Printed educational materials based on existing resources (e.g., AHA; Centers for Disease Control and Prevention) will be shared with subjects in this group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment rate
Time Frame: Through study completion (an average of 3 years)
|
Recruitment rate will be evaluated with respect to rate of enrollment, defined as randomization into the trial.
|
Through study completion (an average of 3 years)
|
|
Retention rate
Time Frame: Through study completion (an average of 3 years)
|
Retention rate will be quantified by the proportion of subjects who remain in the study to complete our 9-month visit.
|
Through study completion (an average of 3 years)
|
|
Intervention enjoyment
Time Frame: 6 months
|
Intervention enjoyment will be assessed via qualitative interviews
|
6 months
|
|
Intervention adherence
Time Frame: Through study completion (an average of 3 years)
|
Intervention adherence will be measured by collection of class attendance and home practice data.
|
Through study completion (an average of 3 years)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical activity
Time Frame: Baseline, 6 and 9 months
|
Physical activity will be measured using accelerometers (Actigraph model wGT3X-BT, LLC, Fort Walton Beach, FL).
|
Baseline, 6 and 9 months
|
|
Systolic and diastolic blood pressure
Time Frame: Baseline, 6 and 9 months
|
Blood pressure will be measured using a Dinamap XL automated BP monitor according to current recommendations.
|
Baseline, 6 and 9 months
|
|
Body weight
Time Frame: Baseline, 6 and 9 months
|
Body weight will be measured using an electronic scale.
|
Baseline, 6 and 9 months
|
|
Height
Time Frame: Baseline
|
Height will be measured using a tape measure.
|
Baseline
|
|
Fasting glucose
Time Frame: Baseline, 6 and 9 months
|
Fasting glucose will be measured after a 12-hour fast according to standardized procedures.
All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital.
|
Baseline, 6 and 9 months
|
|
Lipid panel
Time Frame: Baseline, 6 and 9 months
|
Lipid panel will be measured after a 12-hour fast according to standardized procedures.
All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital.
|
Baseline, 6 and 9 months
|
|
hs-CRP
Time Frame: Baseline, 6 and 9 months
|
hs-CRP will be measured after a 12-hour fast according to standardized procedures.
All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital.
|
Baseline, 6 and 9 months
|
|
Quality of life assessed by SF-36
Time Frame: Baseline, 6 and 9 months
|
Quality of life will be measured using a short version (8 items) of the Health Survey Short Form (SF-36).
Scores range from 0-100, with a higher score indicating a higher quality of life.
|
Baseline, 6 and 9 months
|
|
Intrinsic motivation
Time Frame: Baseline, 6 and 9 months
|
Intrinsic Motivation Inventory is a 22-item scale validated with four sub-scales: interest/enjoyment, perceived competence, perceived choice, and pressure/tension.
A higher score is better, with a scoring range of 22-154.
|
Baseline, 6 and 9 months
|
|
Anxiety, Depression
Time Frame: Baseline, 6 and 9 months
|
Anxiety, Depression will be assessed using the Hospital Anxiety and Depression Scale, a self-administered questionnaire with two sub-scales (0-21) measuring anxiety and depression, with higher scores indicating greater psychological morbidity.
|
Baseline, 6 and 9 months
|
|
Stress
Time Frame: Baseline, 6 and 9 months
|
Stress will be measured using the Perceived Stress Scale (PSS) - a 10 items survey with scores ranging from 0 to 40, and higher scores indicating greater stress burden.
|
Baseline, 6 and 9 months
|
|
Mindful awareness
Time Frame: Baseline, 6 and 9 months
|
Mindful awareness will be assessed using the Five Facets of Mindfulness questionnaire (short form) a 15-item questionnaire that measures the five identified components of mindfulness meditation: observing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience.
Scores ranges from 39-19, with a higher score being better.
|
Baseline, 6 and 9 months
|
|
Exercise self-efficacy
Time Frame: Baseline, 6 and 9 months
|
Exercise self-efficacy will be measured using the Self-Efficacy for Exercise Scale.
This is a 9-item validated scale from McAuley's original barriers scale.
Scores range form 9-28, with a higher score meaning more self-efficacy.
|
Baseline, 6 and 9 months
|
|
Exercise capacity
Time Frame: Baseline, 6 and 9 months
|
Exercise capacity will be assessed via the 6 min walk test (6MWT), a simple, safe and reliable first-line assessment of functional status that correlates with peak oxygen uptake.
|
Baseline, 6 and 9 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Socio-demographics
Time Frame: Baseline
|
Age, sex, race/ethnicity, education, income, insurance status will be collected from the EMR using standard abstraction forms.
|
Baseline
|
|
Medical history
Time Frame: Baseline
|
Coronary risk factors; coronary revascularization procedures; ejection fraction; New York Heart Association class; CHD severity (one-, two- or three-vessel from coronary angiogram); co-morbidities; CR information (history of participation, reasons for decline); comorbidities (Charlson index); medications] will be abstracted from medical records using standard abstraction forms that have been validated in previous studies.
|
Baseline
|
|
Social support
Time Frame: Baseline
|
Social support will be measured with the Multidimensional Scale of Perceived Social Support is a 12-item, unidimensional tool to measure how one perceives their social support system, including the individual's sources of social support (i.e., family, friends, and significant others).
Scores range from 12-84, with a higher score meaning more perceived social support.
|
Baseline
|
|
Neighborhood barriers to physical activity
Time Frame: Baseline
|
PANES (Physical Activity Neighborhood Environment Survey) also known as the International Physical Activity Prevalence Study Self-Administered Environmental Module is a 17-item Scale that can be used to assess the environmental factors for walking and bicycling in various neighborhoods.
Scores range from 17-68, with higher scores indicating a neighborhood environment that is more conducive to physical activity.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 27, 2024
Primary Completion (Estimated)
June 15, 2026
Study Completion (Estimated)
June 15, 2026
Study Registration Dates
First Submitted
January 6, 2023
First Submitted That Met QC Criteria
January 17, 2023
First Posted (Actual)
January 26, 2023
Study Record Updates
Last Update Posted (Actual)
February 4, 2026
Last Update Submitted That Met QC Criteria
February 2, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022P000891
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndrome
-
Chulalongkorn UniversityCompletedCKD | Coronary Angiography (CAG) | ACS (Acute Coronary Syndrome)
-
Universitätsklinikum Hamburg-EppendorfGesellschaft für Therapieforschung mbH; Deutsches Zentrum für Herz-Kreislauf-Forschung... and other collaboratorsNot yet recruitingSCAD | ACS (Acute Coronary Syndrome)United Kingdom, Germany, Canada, Netherlands, Sweden
-
Samsung Medical CenterNot yet recruitingAcute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
-
Mahidol UniversityNot yet recruitingCoronary Artery Disease | Acute Coronary Syndrome/ Myocardial InfarctionThailand
-
Shenyang Northern HospitalNot yet recruitingSGLT2 Inhibitors | ACS (Acute Coronary Syndrome)China
-
Aarhus University Hospital SkejbyAbbottEnrolling by invitationIschemic Heart Disease | Ischemic Coronary Artery Disease | ACS (Acute Coronary Syndrome)Denmark, Belgium, Germany, Finland, Sweden, Switzerland, Latvia, Norway, United Kingdom, Estonia, Netherlands, Italy
-
Heart Care FoundationNovartis Farma S.p.A.Not yet recruitingAcute Coronary Syndromes | Chronic Coronary SyndromesItaly
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Xiling QiRecruitingHF - Heart Failure | ACS (Acute Coronary Syndrome)China
Clinical Trials on Tai chi + wearable
-
Harvard University Faculty of MedicineBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompleted
-
Lidian ChenPeking University Third HospitalNot yet recruiting
-
Chengdu University of Traditional Chinese MedicineNot yet recruitingQuality of Life | Dialysis; Complications | Chinese Medicine
-
Jinan University GuangzhouChaozhou Special Education SchoolCompleted
-
University Hospital, Clermont-FerrandCompleted
-
Taipei Veterans General Hospital, TaiwanNational Science Council, TaiwanCompleted
-
Hartford HospitalRecruiting
-
Texas Tech University Health Sciences CenterCompleted
-
Chang Gung Memorial HospitalCompleted
-
Massachusetts General HospitalUnknown